tobramycin has been researched along with Adenocarcinoma Of Kidney in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ankenbruck, N; Connelly, CM; Deiters, A; Gardner, L; Naro, Y; Thomas, M; Tivon, Y | 1 |
1 other study(ies) available for tobramycin and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Small Molecule Inhibition of MicroRNA miR-21 Rescues Chemosensitivity of Renal-Cell Carcinoma to Topotecan.
Topics: Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Kidney Neoplasms; MicroRNAs; Small Molecule Libraries; Topotecan | 2018 |